Cargando…
CDC20 Is Regulated by the Histone Methyltransferase, KMT5A, in Castration-Resistant Prostate Cancer
SIMPLE SUMMARY: The methyltransferase KMT5A is suggested as an oncogene in prostate cancer but the mechanisms underlying its oncogenic properties are poorly understood. This study uncovers genes and cellular pathways which are regulated by KMT5A in prostate cancer to obtain a better understanding of...
Autores principales: | Alebady, Zainab A. H., Azizyan, Mahsa, Nakjang, Sirintra, Lishman-Walker, Emma, Al-Kharaif, Dhuha, Walker, Scott, Choo, Hui Xian, Garnham, Rebecca, Scott, Emma, Johnson, Katya L., Robson, Craig N., Coffey, Kelly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377584/ https://www.ncbi.nlm.nih.gov/pubmed/37509260 http://dx.doi.org/10.3390/cancers15143597 |
Ejemplares similares
-
The novel anti-androgen candidate galeterone targets deubiquitinating enzymes, USP12 and USP46, to control prostate cancer growth and survival
por: McClurg, Urszula L., et al.
Publicado: (2018) -
FOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancer
por: Jones, Dominic, et al.
Publicado: (2015) -
Cancer-epigenetic function of the histone methyltransferase KMT2D and therapeutic opportunities for the treatment of KMT2D-deficient tumors
por: Dhar, Shilpa S., et al.
Publicado: (2021) -
Differential regulation of the androgen receptor by protein phosphatase regulatory subunits
por: Grey, James, et al.
Publicado: (2017) -
Histone methyltransferase KMT2D contributes to the protection of myocardial ischemic injury
por: Liu, Shu-Bao, et al.
Publicado: (2022)